Skip to main content
TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.30
-0.10 (-0.20%)
May 12, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cardiovascular and Gastrointestinal Drugs
565.24M
Log In
Log In
Log In
Log In
Cardiovascular and Gastrointestinal Drugs Growth
13.66%
Log In
Log In
Log In
Log In
Reinvestment
550.48M
Log In
Log In
Log In
Log In
Reinvestment Growth
75.53%
Log In
Log In
Log In
Log In
Lozenges
-
Log In
Log In
Log In
Log In
Lozenges Growth
-
Log In
Log In
Log In
Log In
Testing
-
Log In
Log In
Log In
Log In
Testing Growth
-
Log In
Log In
Log In
Log In
Capsules
-
Log In
Log In
Log In
Log In
Capsules Growth
-
Log In
Log In
Log In
Log In
Service
-
Log In
Log In
Log In
Log In
Service Growth
-
Log In
Log In
Log In
Log In
Injections
-
Log In
Log In
Log In
Log In
Injections Growth
-
Log In
Log In
Log In
Log In
Sales Returns and Allowances
-
Log In
Log In
Log In
Log In
Sales Returns and Allowances Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Taiwan
1.12B
Log In
Log In
Log In
Log In
Taiwan Growth
37.59%
Log In
Log In
Log In
Log In